NewsRx

Search our medical news database

C. R. Bard, Inc.

Court Rules in Favor of Bard on Patent Infringement Suit against W. L. Gore & Associates

Published in Surgery Litigation and Law Weekly, August 22nd, 2008

C. R. Bard, Inc. (NYSE: BCR) announced that a U.S. District Court in Arizona entered judgment in Bard's favor in its patent infringement suit against W. L. Gore & Associates. The Court ruled that Gore failed to prove that Bard's patent number 6,436,135 was unenforceable due to inequitable conduct. As previously announced, on December 11, 2007, a jury found that Gore willfully infringed Bard's patent through the sale of Gore's ePTFE vascular grafts and stent-grafts, and awarded Bard $185 million in past damages.

Gore may file post-trial motions with the court and may appeal the judgment to the Court of Appeals for the Federal Circuit.

C. R. Bard,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook